TP53 intron 6 polymorphism and the risk of ovarian and breast cancer
1998

TP53 Intron 6 Polymorphism and Cancer Risk

Sample size: 672 publication Evidence: moderate

Author Information

Author(s): D Mavridou, R Gornall, I G Campbell, D M Eccles

Primary Institution: University of Southampton

Hypothesis

Does the TP53 intron 6 polymorphism increase the risk of ovarian and breast cancer?

Conclusion

The study found a significant association between the N' allele of the TP53 intron 6 polymorphism and ovarian cancer, but not with breast cancer.

Supporting Evidence

  • The study involved 224 women with ovarian cancer, 224 with breast cancer, and 254 control subjects.
  • The N' allele was significantly more prevalent in ovarian cancer patients compared to controls.
  • There was no significant difference in the prevalence of the N' allele in breast cancer patients compared to controls.

Takeaway

Scientists looked at a specific change in a gene called TP53 to see if it makes women more likely to get ovarian or breast cancer. They found it might be linked to ovarian cancer but not breast cancer.

Methodology

The frequency of TP53 intron 6 polymorphism alleles was investigated in women with ovarian and breast cancer and compared to control subjects using PCR and sequencing.

Limitations

The findings need to be confirmed in other populations due to previous conflicting reports.

Participant Demographics

All participants were Caucasian women from southern England.

Statistical Information

P-Value

0.01

Statistical Significance

p=0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication